Learn More About Cancer Treatment Centers of America: Chat with Us | Email Us
Sutent® - The trade name for sunitinib (or sunitinib malate), Sutent® is an oral chemotherapy drug. Sutent® is used in the treatment of advanced renal cell carcinoma, and gastrointestinal stromal tumors (GIST) that have not responded to another drug called imatinib. Sutent® is a type of tyrosine kinase inhibitor, vascular endothelial growth factor (VEGF) receptor inhibitor, and angiogenesis inhibitor. Sutent® works against cancerous cells by interfering with cancer cells' ability to communicate and reproduce.
Previous: Surgical Oncology
Back to the Cancer Glossary